Conference Schedule
October 22, 2024
08:00
Registration Open
Welcome Breakfast and Networking
09:00
Opening Remarks from the Conference Chairs
James Donohue, Senior Digital Health Lead, Genentech
Anna Yang, Principal, Clinical Innovation & Technology Leader, Genentech
09:05
FIRESIDE CHAT
Responsible Innovation
As an industry, how do we continue to innovate in a responsible and sustainable way in environments that are resource-constrained?
Shiva Amiri, Partner, VP, Head of AI and Data Intelligence, Pivotal Life Sciences
Lee Lehman-Becker, SVP, Global Head of Healthcare Insights, Roche
09:25
CASE STUDY
Natural Language Query of Real World Data Using LLM Based Chatbots
Mukul Virmani, Director, Clinical Data Science, Advanced Analytics,
Gilead Sciences 09:40
CASE STUDY
The Path to Singularity: AI's Role in Fast-Tracking Clinical Trials
Tyler Pugsley, SVP,
Medable
• Conceptualizing the Use of AI in Clinical Trials - Internal Processes and Operations
• Current AI Trends in Clinical Trials
• Real-World Applications
• Future Outlook: Understanding the Full Opportunity
Shun Zhang, Director of AI, AstraZeneca
Dr. Prasun Mishra, Founder and CEO, Agility Pharmaceuticals
Mukul Virmani, Director, Clinical Data Science, Advanced Analytics, Gilead Sciences
Katherine Wang, AI Product & Strategy Lead, Palantir
Moderated by: Paquita Chang, Data Scientist, Genentech
• What are sponsors doing right / wrong?
• How have or how can digital solutions / AI help improve the patient experience?
Moderated by: Rozanno Gonzales, Clinical Innovation and Technology Leader, Genentech
11:20
Optimizing Patient Choice, Flexibility, and Outcomes by Personalizing the Clinical Trial Experience
Whitley Albright, Clinical Innovation and Operations Strategy Lead, Sanofi
11:40
CASE STUDY
Outcome Measures: What They Are, Why They Matter, & How the Use of Outcome Measures can Change Clinical Trials
Caprice Sassano, Outcomes Research Lead, ICON plc
12:00
SPONSOR PANEL
Making Trials More Human-Centric
• What has changed from a sponsor perspective to innovate and implement more tangible solutions that have made trials more human-centric?
Whitley Albright, Clinical Innovation and Operations Strategy Lead, Sanofi
Caprice Sassano, Outcomes Research Lead, ICON plc
Archana Sah, Founder and CEO, AS Pharma Advisors
Moderated by: Venu Vittaladevuni, Director of Patient & Customer Engagement, Genentech
01:20
Afternoon Welcoming Remarks
James Donohue, Senior Digital Health Lead, Genentech
01:25
Harnessing Diverse Voices for Inclusive Research: The Power of Employee Resource Groups
Ivy Kam, Director, DEI Sciences, Regeneron
01:40
PANEL
Latest Strategies to Solve for Evolving Market Challenges and Demands to Ensure Trials are Accessible
This panel will bring together clinical operations leaders to share what they are doing in their organizations to address diversity, equity, and inclusion in clinical trials.
Ivy Kam, Director, DEI Sciences, Regeneron
Meghan McKenzie, Principal, Patient Inclusion & Health Equity, Chief Diversity Office, Genentech
Moderated by: Shalini Mohan, Head of Health Equity and Inclusive Research, Genentech
02:00
FIRESIDE CHAT
Impact of Emerging Regulations on Operationalizing Trials
Ana Sousa, Chief Regulatory Officer, Aspen Neuroscience
Barbara Elashoff, Biostatistician, Pivotal Life Sciences
Led by Rasika Kalamegham, Head of US Regulatory Policy, Genentech
02:25
AFTERNOON COFFEE BREAK
03:00
CASE STUDY
Incorporating the Voice of the Patient into Clinical Trials
Krista Leonard-Corzo, Lead Research Scientist, Vivosense
03:20
CASE STUDY
Approaches in DCT Metrics From Two Sponsor Companies: Genentech and Astellas
Janet Moga, DCT Operations Lead, Astellas Pharma
Anna Yang, Principal, Clinical Innovation & Technology Leader, Genentech
Joint Q&A to Follow
03:50
CASE STUDY
Revolutionizing Clinical Trial Central Monitoring: Automated Quality Assurance for Faster, Scalable Monitoring
Rachel Newsome, Product Manager, Cambridge Cognition
04:10
FIRESIDE CHAT
Common Threats to Data Quality/Integrity from DHTs: The importance of Operational Oversight
Kate Lyden, CSO, Vivosense
Tom Switzer, Head, Digital Health, gRED, Genentech
04:30
Closing Reflections
James Donohue, Senior Digital Health Lead, Genentech
Anna Yang, Principal, Clinical Innovation & Technology Leader, Genentech
Rozanno Gonzales, Clinical Innovation and Technology Leader, Genentech
APÉRO / NETWORKING RECEPTION TO FOLLOW